Comparative Analysis of Annual Relapse Rates (ARR) in Multiple Sclerosis Patients Treated with Different Disease-Modify Therapies.
Phase of Trial: Phase IV
Latest Information Update: 18 Nov 2016
At a glance
- Drugs Dimethyl fumarate (Primary) ; Fingolimod (Primary) ; Glatiramer acetate (Primary) ; Interferons (Primary) ; Teriflunomide (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 18 Nov 2016 New trial record